Last reviewed · How we verify
n3 polyunsaturated fatty acid
N3 polyunsaturated fatty acids are involved in the regulation of inflammation and may have anti-inflammatory effects.
N3 polyunsaturated fatty acids are involved in the regulation of inflammation and may have anti-inflammatory effects. Used for Hypertriglyceridemia.
At a glance
| Generic name | n3 polyunsaturated fatty acid |
|---|---|
| Sponsor | University Hospital, Clermont-Ferrand |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
N3 polyunsaturated fatty acids, such as EPA and DHA, are known to have anti-inflammatory properties by inhibiting the production of pro-inflammatory eicosanoids and cytokines. This may contribute to their potential therapeutic benefits in various conditions.
Approved indications
- Hypertriglyceridemia
Common side effects
- Fishy aftertaste
Key clinical trials
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction (PHASE2)
- Pre-Surgical Immunonutrition's Effect on Colorectal Surgery (NA)
- Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia (PHASE2)
- FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (PHASE2)
- Heart & Health Study (NA)
- NMDA Enhancement Combined With Omega-3 for Early Dementia (PHASE2)
- A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth (PHASE4)
- Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen? (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |